The North America Hospital Acquired Infection Control Market was valued at USD 8,400 Million in 2025 and is projected to reach USD 15,675 Million by 2035, growing at a CAGR of 5.8% during the forecast period (2024–2035). The market is driven by increasing awareness, stringent regulations, and technological advancements in infection control, predominantly in the US and Canada. Key players such as STERIS, Getinge AB, and 3M are continuously introducing cutting-edge products and forming strategic collaborations to meet rising demand and improve patient safety across healthcare facilities.
The economic impact of tariffs on "North America Hospital Acquired Infection Control Market".
Market Growth Drivers
Rising Healthcare-Associated Infection (HAI) Rates: Increasing incidences of hospital-acquired infections in North America are pressuring healthcare institutions to adopt robust infection control measures. According to the Centers for Disease Control and Prevention (CDC), hundreds of thousands of patients are affected by HAIs annually, leading to higher healthcare costs and mortality. In response, companies like STERIS and 3M are expanding their portfolios of sterilization and disinfection solutions, ensuring greater protection against common pathogens and antibiotic-resistant bacteria.
Stringent Regulatory Guidelines: Regulatory authorities such as the FDA and Health Canada have imposed strict mandates for infection control compliance in hospitals and clinics. This is compelling facilities to invest in advanced infection prevention technologies, such as automated UV disinfection robots and real-time surveillance systems. Getinge AB, for instance, has seen increased uptake of its sterilization equipment following regulatory reforms, enabling healthcare providers to maintain compliance and minimize infection rates.
Market Trends
Adoption of Artificial Intelligence (AI) & Automation: Hospitals across North America are integrating AI and automation to enhance infection prevention protocols. AI-powered analytics help track infection trends, predict outbreaks, and streamline cleaning schedules. Companies like 3M have launched smart monitoring systems and data-driven platforms, enabling early detection and intervention. This technological trend is making real-time infection prevention more accurate and efficient.
Sustainable and Eco-friendly Solutions: As environmental concerns escalate, healthcare providers are seeking sustainable alternatives for disinfection and sterilization. Companies such as Ecolab are introducing biodegradable disinfectants and low-energy sterilization processes. Hospitals are increasingly choosing products with minimal chemical residues and reduced environmental impact, aligning infection control procedures with broader sustainability goals.
Market Opportunities
Expansion into Outpatient and Ambulatory Settings: With rising volumes of outpatient procedures, there is significant opportunity for companies to provide tailored infection control solutions for ambulatory surgical centers and clinics. STERIS and Cantel Medical are expanding their reach into these fast-growing settings.
Growth Through Strategic Partnerships: Collaborative initiatives between healthcare providers and industry players, such as co-developing innovative sterilization devices, present ample growth opportunities. Getinge AB's partnership with leading healthcare networks in the US has accelerated product adoption and market penetration.
North America Hospital Acquired Infection Control Market Revenue (USD Million), 2020-2035
The revenue chart demonstrates a steady upward trend in the North America Hospital Acquired Infection Control Market from 2020 to 2035, starting at USD 5,700 Million in 2020 and reaching USD 15,675 Million by 2035. The most significant growth is observed from 2025 onwards, attributed to the implementation of stricter infection control mandates and rapid technological adoption. This growth trajectory underscores rising healthcare investments and persistent demand for advanced infection control products in hospitals and clinics across North America.
North America Hospital Acquired Infection Control Market by Region Share (%), 2025
In 2025, the United States dominates the North America Hospital Acquired Infection Control Market, accounting for 78% of the total market share, driven by extensive healthcare infrastructure, regulatory initiatives, and the widespread adoption of advanced infection control solutions. Canada follows with 16%, benefiting from increasing investments in hospital safety. Mexico and the Caribbean comprise smaller shares, reflecting gradual improvements in infection control standards. Overall, this regional distribution highlights the central role of the US in propelling market growth across North America.
Recent Developments
In March 2024, 3M launched an AI-powered infection surveillance platform designed to enhance HAI detection and reporting for hospitals. The new system integrates seamlessly with existing hospital record systems, supporting healthcare workers in early identification and containment of potential outbreaks, leading to improved compliance with health regulations.
In April 2024, STERIS announced the acquisition of a leading UV-C disinfection start-up, strengthening its position in the surface sterilization market. The deal will enable STERIS to expand its product lineup with next-generation UV disinfection solutions, helping hospitals achieve higher levels of environmental hygiene and safety.
In February 2024, Ecolab introduced an eco-friendly, biodegradable disinfectant specifically designed for high-traffic healthcare environments. The innovation aligns with growing hospital demands for sustainable solutions, granting healthcare facilities a safer and greener alternative for routine disinfection—without compromising effectiveness.
Press Releases